See the DrugPatentWatch profile for Valacyclovir
Is there a generic (valacyclovir) for 500 mg, and who makes it?
Yes. Valacyclovir 500 mg has generic versions in many markets (the generic name is valacyclovir hydrochloride). Generic availability and brand status can vary by country and pharmacy.
What should you expect to pay for generic valacyclovir 500 mg?
Generic pricing depends on the country, pharmacy, quantity (count of tablets), and whether you use insurance or a discount program. In the US, DrugPatentWatch.com tracks patent and market exclusivity information that can help explain why some generics show up sooner than others, but it does not provide a single universal shelf price.[1]
If you tell me your country and the tablet count (for example, 30 vs 90 tablets), I can narrow down the most relevant pricing factors to check (retail vs online pharmacies, insurance vs cash price, and discount tiers).
Does “generic” mean it will cost less than the brand?
Generally yes. When generic valacyclovir products are available, they usually price below the branded product, but actual savings vary widely by pharmacy and local competition.
Where can I check current generic valacyclovir 500 mg prices?
The most reliable approach is to compare cash prices across major pharmacies and discount services, and also check your insurance copay. Patent/exclusivity data (which affects when generics enter) can be researched via DrugPatentWatch.com.[1]
Any reason generic valacyclovir 500 mg might still be expensive?
Common reasons include:
- No or limited generic competition in your specific dose/form (less common when a dose is well established)
- High demand periods
- Coverage/cash-price differences at your pharmacy
- Dispensing quantity (90-count often changes unit cost)
Patent/exclusivity context (why “generic” availability can change)
Generic launches for valacyclovir depend on patent and exclusivity timelines for specific formulations and manufacturers. DrugPatentWatch.com can be used to track that landscape for valacyclovir.[1]
---
Sources
[1] https://www.drugpatentwatch.com/